Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nkarta, Inc.NKTX · Entity 6346 | Chief Scientific Officer | June 18, 2024 | June 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nkarta, Inc.
Report date June 18, 2024 · Filed June 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 150,959 |
Reported balance
After 2024-06-18 transaction · row 1
1 source rowRow 1 · 2024-06-18 · Sale · Disposed 456 · Balance 150,959 F1: Represents shares sold as required by the applicable award terms to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person. F2: This transaction was executed in multiple trades at prices ranging from $5.56 to $5.60. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold as required by the applicable award terms to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person.
F2: This transaction was executed in multiple trades at prices ranging from $5.56 to $5.60. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2024 Filed Jun 20, 2024 17:04 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 456 | $5.60 | $2,553.60 |
DisclosureSEC source: 0000950170-24-075733 · ownership.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,959 F1 · shares: Represents shares sold as required by the applicable award terms to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $5.56 to $5.60. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:12 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 4,143 | $12.00 | $49,716.00 |
DisclosureSEC source: 0000950170-24-015564 · ownership.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,415 F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and most recently amended on June 22, 2022. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 16:43 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 4,560 | $8.74 | $39,854.40 |
DisclosureSEC source: 0000950170-24-005429 · ownership.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,558 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $8.74 to $8.96. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 16:48 UTC | Nkarta, Inc. NKTX · Entity 6346 | GrantStock Option (right to buy) · Derivative | 112,500 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001209191-24-001161 · doc4.xml · derivative · entry 2 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 112,500 shares Expires 2034-01-03 F3 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2024. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 16:48 UTC | Nkarta, Inc. NKTX · Entity 6346 | GrantCommon Stock | 56,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001161 · doc4.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,118 F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on January 14, 2025. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. F2 · balance_after: Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on November 30, 2023. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 16:26 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 439 | $4.85 | $2,129.15 |
DisclosureSEC source: 0001209191-23-039061 · doc4.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,118 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person. F2 · balance_after: Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2023. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 19:05 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 1,115 | $5.49 | $6,121.35 |
DisclosureSEC source: 0001209191-23-003857 · doc4.xml · nonDerivative · entry 2 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,557 F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a discretionary transaction by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $5.49 to $5.56. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 19:05 UTC | Nkarta, Inc. NKTX · Entity 6346 | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0001209191-23-003857 · doc4.xml · derivative · entry 3 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-01-12 F4 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2023. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 19:05 UTC | Nkarta, Inc. NKTX · Entity 6346 | GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003857 · doc4.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,672 F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on January 14, 2024. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 16:21 UTC | Nkarta, Inc. NKTX · Entity 6346 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0000899243-22-028991 · doc4.xml · derivative · entry 3 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,243 Underlying: Common Stock · 5,000 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 30 days prior to the trade date. F3 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 16:21 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 5,000 | $17.53 | $87,655.50 |
DisclosureSEC source: 0000899243-22-028991 · doc4.xml · nonDerivative · entry 2 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,172 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 30 days prior to the trade date. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.50 to $17.62. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 16:21 UTC | Nkarta, Inc. NKTX · Entity 6346 | Exercise / conversionCommon Stock | 5,000 | $3.89 | $19,450.00 |
DisclosureSEC source: 0000899243-22-028991 · doc4.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 30 days prior to the trade date. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 19:07 UTC | Nkarta, Inc. NKTX · Entity 6346 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $12.25 | $0.00 |
DisclosureSEC source: 0001209191-22-038525 · doc4.xml · derivative · entry 2 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-06-16 F2 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following June 17, 2022. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 19:07 UTC | Nkarta, Inc. NKTX · Entity 6346 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038525 · doc4.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,172 F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 16:50 UTC | Nkarta, Inc. NKTX · Entity 6346 | GrantStock Option (right to buy) · Derivative | 76,800 | $0.00 Strike: $12.14 | $0.00 |
DisclosureSEC source: 0001209191-22-003754 · doc4.xml · derivative · entry 2 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,800 Underlying: Common Stock · 76,800 shares Expires 2032-01-13 F2 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2022. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 16:50 UTC | Nkarta, Inc. NKTX · Entity 6346 | GrantCommon Stock | 12,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003754 · doc4.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,172 F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 16:50 UTC | Nkarta, Inc. NKTX · Entity 6346 | Exercise / conversionStock Option (right to buy) · Derivative | 2,250 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0000899243-21-031622 · doc4.xml · derivative · entry 3 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,412 Underlying: Common Stock · 2,250 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · derivative.exercise_date: This option originally covered 62,162 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 1, 2020. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 16:50 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 3,600 | $31.53 | $113,508.00 |
DisclosureSEC source: 0000899243-21-031622 · doc4.xml · nonDerivative · entry 2 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,372 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 16:50 UTC | Nkarta, Inc. NKTX · Entity 6346 | Exercise / conversionCommon Stock | 2,250 | $3.89 | $8,752.50 |
DisclosureSEC source: 0000899243-21-031622 · doc4.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| May 03, 2021 Filed May 5, 2021 14:00 UTC | Nkarta, Inc. NKTX · Entity 6346 | Exercise / conversionStock Option (right to buy) · Derivative | 2,250 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0000899243-21-018300 · doc4.xml · derivative · entry 4 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,662 Underlying: Common Stock · 2,250 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · derivative.exercise_date: This option originally covered 62,162 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 1, 2020. Read SEC document |
| May 03, 2021 Filed May 5, 2021 14:00 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 2,250 | $31.64 | $71,190.00 |
DisclosureSEC source: 0000899243-21-018300 · doc4.xml · nonDerivative · entry 3 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,722 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| May 03, 2021 Filed May 5, 2021 14:00 UTC | Nkarta, Inc. NKTX · Entity 6346 | Exercise / conversionCommon Stock | 2,250 | $3.89 | $8,752.50 |
DisclosureSEC source: 0000899243-21-018300 · doc4.xml · nonDerivative · entry 2 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| May 03, 2021 Filed May 5, 2021 14:00 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 1,350 | $31.64 | $42,714.00 |
DisclosureSEC source: 0000899243-21-018300 · doc4.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,722 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 19:48 UTC | Nkarta, Inc. NKTX · Entity 6346 | Exercise / conversionStock Option (right to buy) · Derivative | 2,800 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-21-004788 · doc4.xml · derivative · entry 7 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,600 Underlying: Common Stock · 2,800 shares Expires 2030-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F5 · derivative.exercise_date: This option originally covered 82,400 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 19:48 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 2,800 | $40.00 | $112,000.00 |
DisclosureSEC source: 0000899243-21-004788 · doc4.xml · nonDerivative · entry 5 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,072 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 19:48 UTC | Nkarta, Inc. NKTX · Entity 6346 | Exercise / conversionCommon Stock | 2,800 | $18.00 | $50,400.00 |
DisclosureSEC source: 0000899243-21-004788 · doc4.xml · nonDerivative · entry 4 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,872 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 19:48 UTC | Nkarta, Inc. NKTX · Entity 6346 | Exercise / conversionStock Option (right to buy) · Derivative | 2,250 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0000899243-21-004788 · doc4.xml · derivative · entry 6 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,912 Underlying: Common Stock · 2,250 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F4 · derivative.exercise_date: This option originally covered 62,162 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following September 5, 2019. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 19:48 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 1,566 | $39.46 | $61,794.36 |
DisclosureSEC source: 0000899243-21-004788 · doc4.xml · nonDerivative · entry 3 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,072 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · price: This transaction was executed in multiple trades at prices ranging from $39.00 to $39.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 19:48 UTC | Nkarta, Inc. NKTX · Entity 6346 | SaleCommon Stock | 2,034 | $38.07 | $77,434.38 |
DisclosureSEC source: 0000899243-21-004788 · doc4.xml · nonDerivative · entry 2 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,638 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · price: This transaction was executed in multiple trades at prices ranging from $37.71 to $38.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 19:48 UTC | Nkarta, Inc. NKTX · Entity 6346 | Exercise / conversionCommon Stock | 2,250 | $3.89 | $8,752.50 |
DisclosureSEC source: 0000899243-21-004788 · doc4.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 13:22 UTC | Nkarta, Inc. NKTX · Entity 6346 | GrantStock Option (right to buy) · Derivative | 52,500 | $0.00 Strike: $54.89 | $0.00 |
DisclosureSEC source: 0000899243-21-001462 · doc4.xml · derivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2031-01-07 F1 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 8, 2021. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 21:56 UTC | Nkarta, Inc. NKTX · Entity 6346 | GrantStock Option (right to buy) · Derivative | 31,100 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019049 · doc4.xml · derivative · entry 2 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,100 Underlying: Common Stock · 31,100 shares Expires 2030-06-30 F2 · derivative.exercise_date: This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 1, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 21:56 UTC | Nkarta, Inc. NKTX · Entity 6346 | GrantStock Option (right to buy) · Derivative | 82,400 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019049 · doc4.xml · derivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,400 Underlying: Common Stock · 82,400 shares Expires 2030-07-08 F1 · derivative.exercise_date: This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.